| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 03/11/2004 | US20040048828 Immunosuppressive agent and food |
| 03/11/2004 | US20040048820 Prevention or therapy of cardiovascular complications |
| 03/11/2004 | US20040048819 Complexes for transferring nucleic acids into cells |
| 03/11/2004 | US20040048795 Stimulating a vagus nerve pathway in the brain; inhibiting apoptosis of a cardiac myocyte |
| 03/11/2004 | US20040048789 Pharmaceutical compositions |
| 03/11/2004 | US20040048774 Inhibitors of IMPDH enzyme |
| 03/11/2004 | US20040048338 IL-17 receptor like molecules and uses thereof |
| 03/11/2004 | US20040048325 Glycosyltransferase inhibitors |
| 03/11/2004 | US20040048294 Diagnostic and therapeutic methods useful for diagnosing and treating diseases, disorders, and/or conditions related to these novel human secreted proteins |
| 03/11/2004 | US20040048263 Novel g protein-coupled receptor protein and dna thereof |
| 03/11/2004 | US20040048256 Isolated polypeptide of given sequence; use in screening for identifying therapeutic antibodies and drugs |
| 03/11/2004 | US20040048245 Isolated polypeptide of given sequence; identifying modulators by contacting with compound and detecting binding activity; use in diagnosis and treatment |
| 03/11/2004 | US20040047925 Process for enhancing immune response in canines using a dietary composition including garlic |
| 03/11/2004 | US20040047896 Composition for improving age-related physiological deficits and increasing longevity |
| 03/11/2004 | US20040047894 Preparation for improved dietary utilisation |
| 03/11/2004 | US20040047883 For producing drug for stimulating the immune defences of the organism towards viral, parasitic or bacterial infections or cancerous antigens |
| 03/11/2004 | US20040047882 Use of an oil-in-water emulsion as adjuvant for vaccines to be applied contralaterally, the emulsion comprising approx. 5% squalene, 0.5% polysorbate 80 and 0.5% sorbitan trioleate in aqueous citrate buffer pH 6.5 |
| 03/11/2004 | US20040047877 Immunodominant human T-cell epitopes of hepatitis C virus |
| 03/11/2004 | US20040047874 Inhibition of antigen presentation with poorly catabolized polymers |
| 03/11/2004 | US20040047869 Adjuvant composition comprising an immunostimulatory oligonucleotide and a tocol |
| 03/11/2004 | US20040047867 Adjuvant composition comprising FHA protein or a fragment of FHA protein in its free form |
| 03/11/2004 | US20040047860 Antibodies to human mcp-1 |
| 03/11/2004 | US20040047851 Treating a subject suffering from a condition associated with an extracellular zinc sphingomyelinase activity which comprises administering to the subject an amount of a zinc sphingomyelinase inhibitors effective to decrease |
| 03/11/2004 | US20040047837 An autologous vaccine to tumor cells is produced by transducing the tumor cells with a herpes virus amplicon containing the gene for an immunomodulatory protein to provide transient expression of the immunomodulatory protein |
| 03/11/2004 | DE10240894A1 Verstärkung der Resorption von Subtanzen über die Haut und Schleimhaut Enhance the absorption of Subtanzen through the skin and mucous membrane |
| 03/11/2004 | CA2706622A1 Lps activation of phagocytic activity |
| 03/11/2004 | CA2497086A1 Method of controlling pharmacokinetics of immunomodulatory compounds |
| 03/11/2004 | CA2497047A1 Adzymes and uses thereof |
| 03/11/2004 | CA2496948A1 Il-14 vaccine for the treatment of asthma and atopic disorders |
| 03/11/2004 | CA2496607A1 Vaccine comprising il-13 and an adjuvant |
| 03/11/2004 | CA2496409A1 Immunogenic composition comprising an il-13 element and t cell epitopes, and its therapeutic use |
| 03/11/2004 | CA2495914A1 N-biarylmethyl aminocycloalkanecarboxamide derivatives |
| 03/11/2004 | CA2495853A1 2,5-dioxoimidazolidin-4-yl acetamides and analogues as inhibitors of metalloproteinase mmp12 |
| 03/11/2004 | CA2495437A1 Novel crystal |
| 03/11/2004 | CA2494981A1 Production of multimeric fusion proteins using a c4bp scaffold |
| 03/11/2004 | CA2492645A1 Novel combination of glucocorticoids and pde-4-inhibitors for treating respiratory diseases, allergic diseases, asthma and copd |
| 03/10/2004 | EP1396542A2 Novel P-selectin ligand protein |
| 03/10/2004 | EP1396493A1 Heterocyclic compounds |
| 03/10/2004 | EP1396492A1 Prodrug of an ice inhibitor |
| 03/10/2004 | EP1396491A2 2-substituted 4,5-diaryl-imidazoles and their use as p38 MAP kinase inhibitors |
| 03/10/2004 | EP1396487A1 Phenylpyridine carbonyl piperazine derivative |
| 03/10/2004 | EP1395684A2 New polynucleotides and polypeptides of the ifnalpha-7 gene |
| 03/10/2004 | EP1395605A2 Polymeric immunoglobulin fusion proteins that target low-affinity fcgamma receptors |
| 03/10/2004 | EP1395604A1 Novel anti inflammatory 17.alpha.-heterocyclic-esters of 17.beta.-carbothioate androstane derivatives |
| 03/10/2004 | EP1395590A2 Dihydropyrrolo[1,2-a]indole and tetrahydropyrido[1,2-a]indole derivatives as prostaglandin d2 receptor antagonists |
| 03/10/2004 | EP1395582A1 Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same |
| 03/10/2004 | EP1395575A1 4-(penyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 03/10/2004 | EP1395571A1 Compounds and methods for the treatment or prevention of flavivirus infections |
| 03/10/2004 | EP1395566A1 Tricyclic compounds useful as angiotensin ii agonists |
| 03/10/2004 | EP1395561A1 Carbamate and oxamide compounds as inhibitors of cytokine production |
| 03/10/2004 | EP1395559A1 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain anxiety or gastrointestinal disorders |
| 03/10/2004 | EP1395538A1 Vitamin d analogues |
| 03/10/2004 | EP1395284A2 Cd4-specific antibody trx1 and uses therefor |
| 03/10/2004 | EP1395281A1 Recombinant mhc molecules useful for manipulation of antigen-specific t-cells |
| 03/10/2004 | EP1395277A1 The use of a gatran for the manufacture of a medicament for the treatment of pulmonary fibrosis |
| 03/10/2004 | EP1395269A1 Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative bacteria, potential pathogenic gram-positive bacteria |
| 03/10/2004 | EP1395268A1 A method of implanting heavy metal such as nobel metal, e.g. gold, and metal for use in implantation |
| 03/10/2004 | EP1395267A2 Therapeutic compositions for modulating the immune response in a mammal and use thereof |
| 03/10/2004 | EP1395262A2 Nucleoside vaccine adjuvants |
| 03/10/2004 | EP1395259A2 Urazole compounds useful as anti-inflammatory agents |
| 03/10/2004 | EP1395226A2 Use of radiopharmaceutical complexes in achieving transplantation tolerance |
| 03/10/2004 | EP0983256B1 Triptolide derivatives useful in the treatment of autoimmune diseases |
| 03/10/2004 | EP0885011B1 Diagnosis of autoimmune diseases of the inner ear based on the detection of myelin protein p zero |
| 03/10/2004 | EP0868198B1 FCepsilon-PE CHIMERIC PROTEIN FOR TARGETED TREATMENT OF ALLERGY RESPONSES, A METHOD FOR ITS PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME |
| 03/10/2004 | EP0854729B1 Improved methods for the production of non-covalently complexed and multivalent proteosome sub-unit vaccines |
| 03/10/2004 | CN1481504A Screening assay for antagonists of human leukocyte receptors |
| 03/10/2004 | CN1481390A Immunomodulatory peptidesderived from heat shock proteins and uses thereof |
| 03/10/2004 | CN1481377A Cyclic Beta-amino acid derivatives as inhibitors of matrix metalloproteases and TNF alhpa |
| 03/10/2004 | CN1481370A Quinazoline derivatives, medicaments contg. said compounds, their utilization and method for prodn. thereof |
| 03/10/2004 | CN1481367A Imidazole and benzimiddzole caspase inhibitors and uses thereof |
| 03/10/2004 | CN1481255A Vaccines |
| 03/10/2004 | CN1481254A Adjuvant compsn comprising immunostimulatory oligonucleotide and tocol |
| 03/10/2004 | CN1481253A Drugs and foods improving quality of life and process for producng same |
| 03/10/2004 | CN1481244A Pharmaceutical formulation contg pyrazolo [4,3-D] pyrinidines, calcium antagonists, prostaglandins or prostaglandin derivatives |
| 03/10/2004 | CN1481243A Pharmaceutical formulation contg. thienopyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives (2) |
| 03/10/2004 | CN1481242A Pharmaceutical formulation contg thienopyrimidines and antithrombotics, calcium-antagonists, prostaglandins or prostaglandin derivatives |
| 03/10/2004 | CN1481238A Aniline derivatives or salts thereof and cytokine prodn inhibitors contg. same |
| 03/10/2004 | CN1480450A 2-aminopropane-1,3-glycol compound, its use as medicine and its synthetic intermediate |
| 03/10/2004 | CN1480214A Vaccinum contg saponin and sterol |
| 03/10/2004 | CN1480208A Combination of medication for reducing poison and synergic action in radiotherapy or chemotherapy as well as its preparing method |
| 03/10/2004 | CN1480207A Spore of gandoderma lucidum for treating disease of autoimmunity |
| 03/10/2004 | CN1480206A Combination of gadol and Chinese caterpillar fungus as well as preparing method |
| 03/10/2004 | CN1480200A Penetrating fluid for acupuncture point of electrotherapeutics |
| 03/10/2004 | CN1480188A Ointment for child's allergic dermatitis |
| 03/10/2004 | CN1480159A Combination of snake powder, scorpion powder and centipede powder as well as its preparing method |
| 03/10/2004 | CN1141118C Prepn method for hualu health nutritive article |
| 03/10/2004 | CN1141095C Preparation containing combination of N-5-methylisoxazole-4-carboxylic acid-(4-trifluoromethy1)-anilid and N-(4 trifluoromethylphenyl)-2-cyano-3-hyroxycrotonic acid amide |
| 03/09/2004 | US6703402 Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof |
| 03/09/2004 | US6703361 Method of treating or preventing Type 1 diabetes by oral administration of insulin |
| 03/09/2004 | CA2323929C Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines |
| 03/09/2004 | CA2322188C The use of fumaric acid derivatives in transplant medicine |
| 03/05/2004 | CA2437690A1 Ganoderma lucidum spores for treatment of autoimmune diseases |
| 03/04/2004 | WO2004018710A2 Diagnosis of chronic rejection |
| 03/04/2004 | WO2004018684A2 T-cell epitopes in staphylococcal enterotoxin b |
| 03/04/2004 | WO2004018681A2 Il-7 drug substance, il- 7 comprising composition, preparation and uses thereof |
| 03/04/2004 | WO2004018496A1 Inhibitors of nucleoside phosphorylases and nucleosidases |
| 03/04/2004 | WO2004018460A1 Amino methyl imidazoles as c5a receptor modulators |
| 03/04/2004 | WO2004018458A1 2-thio-substituted imidazole derivatives and their use in pharmaceutics |
| 03/04/2004 | WO2004018451A1 Pyridazinone-derivatives as pde4 inhibitors |
| 03/04/2004 | WO2004018435A1 Pyrimidine derivatives as modulators of chemokine receptor activity |